RecruitingNCT06106698

Washed Microbiota Transplantation for Clostridioides Difficile Infection

Washed Microbiota Transplantation for Clostridioides Difficile Infection: a Real World Research


Sponsor

The Second Hospital of Nanjing Medical University

Enrollment

100 participants

Start Date

Jul 22, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation (WMT) for patients with Clostridioides Difficile Infection (CDI).


Eligibility

Min Age: 3 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying WMT for people with clostridioides difficile infection. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERWMT

Washed microbiota transplantation refers to the infusion of washed microbiota from healthy donor into patients' gastrointestinal tract. Participants will receive one dose of WMT for CDI. During follow-up, those who have non-response or CDI recurrence within 4-week post-WMT will receive rescue WMT.


Locations(1)

The second affiliated hospital of Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06106698


Related Trials